A randomized, blinded, placebo-controlled study of health and wellness product formulations and their effects on overall health
This is a randomized, blinded, placebo-controlled study conducted with adult participants, age 21 and older and residing in the United States. Eligible participants will (1) endorse a desire for better health during screening; (2) indicate an interest in taking a health and wellness product to potentially help improve their health, and (3) express acceptance in taking a product and not knowing its formulation until the end of the study. Participants with known liver or kidney disease, heavy drinkers, and those who report they are pregnant, trying to become pregnant, or breastfeeding will be excluded. Those taking certain medications will be excluded. Self-reported data will be collected electronically from eligible participants over 5 weeks. Participant reports of health indicators will be collected during baseline, throughout the active period of study product use, and in a final survey. All study assessments will be electronic; there are no in-person visits or assessments for this real-world evidence study.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Enrollment
1,494
Participants will use their Placebo Control Form 1 Capsules as directed for a period of 4 weeks.
Participants will use their Radicle Health Active Study Product 1.1 Capsules as directed for a period of 4 weeks.
Participants will use their Radicle Health Active Study Product 1.2 Capsules as directed for a period of 4 weeks.
Radicle Science, Inc
Del Mar, California, United States
Change in overall health-related quality of life
Mean difference in overall health score as assessed by Patient Reported Outcome Measurement System (PROMIS) 29+2 Profile (PROPr; scale 70-120; with higher scores corresponding to greater overall health across 7 health domains: physical function, ability to participate in social roles and activities, cognitive function, anxiety, depression, fatigue, sleep disturbance, pain interference and pain intensity)
Time frame: 4 weeks
Change in physical function
Mean difference in physical function score as assessed by PROMIS PROPr items related to physical function (scale 4-20; with higher scores corresponding to greater physical function)
Time frame: 4 weeks
Change in feelings of anxiety
Mean difference in feelings of anxiety score as assessed by PROMIS PROPr items related to anxiety (scale 4-20; with higher scores corresponding to more severe feelings of anxiety)
Time frame: 4 weeks
Change in feelings of depression
Mean difference in feelings of depression score as assessed by PROMIS PROPr items related to depression (scale 4-20; with higher scores corresponding to more severe feelings of depression)
Time frame: 4 weeks
Change in fatigue
Mean difference in fatigue score as assessed by PROMIS PROPr questions related to fatigue (scale 4-20; with higher scores corresponding to more severe fatigue)
Time frame: 4 weeks
Change in sleep disturbance
Mean difference in sleep disturbance score as assessed by PROMIS PROPr items related to sleep disturbance (scale 4-20; with higher scores corresponding to greater sleep disturbance)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Participants will use their Radicle Health Active Study Product 1.3 Capsules as directed for a period of 4 weeks.
Time frame: 4 weeks
Change in socialization ability
Mean difference in socialization ability score as assessed by PROMIS PROPr items related to (scale 4-20; with higher scores corresponding to greater ability to participate in social roles and activities)
Time frame: 4 weeks
Change in pain
Mean difference in pain score as assessed by PROMIS PROPr items related to pain (scale 1-15; with higher scores corresponding to greater pain)
Time frame: 4 weeks
Change in cognitive function
Mean difference in cognitive function score as assessed by PROMIS PROPr items related to cognitive function (scale 2-10; with higher scores corresponding to greater cognitive function)
Time frame: 4 weeks
Change in libido
Mean difference in libido score as assessed by PROMIS Sexual Interest 2.0 (scale 2-10; where higher scores correspond to greater interest in sexual activities)
Time frame: 4 weeks
Minimal clinical importance difference (MCID) in overall health-related quality of life
Likelihood of achieving a MCID in overall health-related quality of life, as measured by PROMIS PROPr (scale 70-120; with higher scores corresponding to greater overall health-related quality of life)
Time frame: 4 weeks